Italia markets close in 2 hours 49 minutes

SWTX Jun 2024 25.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
14,300,00 (0,00%)
In data: 12:47PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente14,30
Aperto14,30
Denaro0,00
Domanda0,00
Prezzo d'esercizio25,00
Scadenza2024-06-21
Min-Max giorno14,30 - 14,30
Contratto - Min-MaxN/D
Volume10
Open Interest4
  • GlobeNewswire

    SpringWorks Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

    – Presented additional Phase 3 DeFi data at ASCO demonstrating clinically significant reductions in pain and substantial reductions in tumor volume and T2 hyperintensity with nirogacestat treatment – – Completed enrollment of Phase 2 trial evaluating nirogacestat in patients with ovarian granulosa cell tumors – – Highlighted encouraging Phase 1 and 2 clinical data from emerging pipeline programs at AACR and EHA – STAMFORD, Conn., Aug. 02, 2023 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (